BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioNJ X-ORIGINAL-URL:https://bionj.org X-WR-CALDESC:Events for BioNJ REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20260326T170000 DTEND;TZID=America/New_York:20260326T190000 DTSTAMP:20260502T062927 CREATED:20260225T204822Z LAST-MODIFIED:20260225T205040Z UID:17851-1774544400-1774551600@bionj.org SUMMARY:BioNJ Members Only Mixer DESCRIPTION:Exclusively for BioNJ Members\n\n\n\nThursday\, March 26\, 5:00 p.m.-7:00 p.m. | Registration is $25.Montgomery Innovation Hub\, 23 Orchard Road\, Skillman\, NJ\n\n\n\n\nRegister Today!\n\n\n\n\nYou Asked for It… BioNJ’s Members‑Only Mixer! \n\n\n\nJoin us in person for an evening designed exclusively for BioNJ Members to unwind\, connect and spark new possibilities across the life sciences community. This relaxed\, engaging gathering is your chance to: \n\n\n\n\nConnect with the BioNJ Member community\n\n\n\nMeet BioNJ Board Members\n\n\n\nBuild new relationships\n\n\n\nReconnect with old friends\n\n\n\nDiscover collaborators\, mentors and industry partners\n\n\n\nEnjoy hors d’oeuvres and drinks with one goal in mind: networking\n\n\n\n\nCome for the conversation\, stay for the connections. This is where relationships begin and ideas take flight. URL:https://bionj.org/event/bionj-members-only-mixer/ LOCATION:Montgomery Innovation Hub\, 23 Orchard Road\, Skillman\, New Jersey\, 08558\, United States END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260205T164500 DTEND;TZID=America/New_York:20260205T213000 DTSTAMP:20260502T062927 CREATED:20250623T135559Z LAST-MODIFIED:20260216T074928Z UID:15852-1770309900-1770327000@bionj.org SUMMARY:2026 BioNJ Annual Dinner Meeting & Innovation Celebration DESCRIPTION:Registration is now closed for this event. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThursday\, February 5\, 2026 | 4:45 p.m.-9:30 p.m. | Hilton East BrunswickTickets are $545 for Members and $630 for Future Members.\n\n\n\n\nBecome a Sponsor\n\n\n\n2025 Photo Gallery\n\n\n\n\n\n\n\n\nRegistration is now open for BioNJ’s 33rd Annual Dinner Meeting & Innovation Celebration happening Thursday\, February 5\, 2026\, at the Hilton East Brunswick! \n\n\n\nJoin us for an unforgettable evening of inspiration\, recognition and connection as we spotlight the incredible breakthroughs happening right here in the Garden State. \n\n\n\n\nExperience a unique opportunity to network with hundreds of top industry leaders\, rising innovators\, government officials\, academic pioneers and influential Patient advocates — all in one room\n\n\n\nDon’t miss the presentation of the presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadership by Dr. Sol Barer himself to this year’s honoree\, Dr. Jan van de Winkel\, President and CEO of Genmab\n\n\n\nCelebrate the recipients of the 2026 Innovator Award Honorees made up of New Jersey companies which received a novel FDA approval in 2025\n\n\n\nHelp honor BioNJ’s inaugural Ecosystem Impact Award Honoree\, Kathleen Coviello\, Chief Economic Transformation Officer\, New Jersey Economic Development Authority\n\n\n\nApplaud Patient advocate heroes receiving the Heart of BioNJ Awards\n\n\n\nBe on hand for special surprises and powerful\, moving speakers\n\n\n\nEnjoy a festive Cocktail Hour\, Dinner Program & Dessert Reception\n\n\n\n\n\n\n\n\n\n\nDr. Sol J. Barer HonoreeDr. Jan van de WinkelPresident & CEOGenmab \n\n\n\n\n\n\n\n\n\nAward Presentation byDr. Sol J. BarerFormer ChairCelgene Corp. ChairTeva Pharmaceutical \n\n\n\n\n\n\n\n\n\nEcosystem Impact Award HonoreeKathleen CovielloChief EconomicTransformation OfficerNew Jersey EconomicDevelopment Authority \n\n\n\n\n\n\n\n\n\nHeart of BioNJAward HonoreeJessica KleinPatient Advocacy & Industry Relations LiaisonAcadia Pharmaceuticals \n\n\n\n\n\n\n\n\n\n\n\nHeart of BioNJ Award HonoreePamela ZapataCancer Survivor & Patient Advocate \n\n\n\n\n\n\n\n\n\nHeart of BioNJ Award HonoreeSiobhan BarryCystic Fibrosis Patient Advocate \nhttps://mountainspringsdental.com/ativan-lorazepam/ \n\n\n\n\n\n\n\n\nHeart of BioNJ Award HonoreeConor ReidCystic Fibrosis Patient Advocate \n\n\n\n\n\n \n\n\n\n\n\nJoin us for New Jersey’s can’t-miss life sciences event of the year! \n\n\n\n\n\n\n\nThank You to Our Sponsors \n\n\n\n\n\n\nMark your calendar for New Jersey’s can’t-miss life sciences event of the year! URL:https://bionj.org/event/2026-bionj-annual-dinner-meeting-innovation-celebration/ LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/06/Annual-Dinner-Meeting-2026-Stacked.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251210T000000 DTEND;TZID=America/New_York:20251210T235959 DTSTAMP:20260502T062927 CREATED:20250702T112215Z LAST-MODIFIED:20251027T145925Z UID:16035-1765324800-1765411199@bionj.org SUMMARY:2025 BioNJ Gives Back DESCRIPTION:Exclusive to BioNJ Members Only\n\n\n\nDecember 10\, 2025\n\n\n\n\nBecome a Sponsor\n\n\n\n\nTwo times and locations: \n\n\n\n\n\n\n\n\n\n9:00 a.m.-11:00 a.m.700 US Highway 202/206\, Bridgewater \n\n\n\n\nRegister Today!\n\n\n\n\n\n\n\n\n\n\n2:00 p.m.-4:00 p.m. M Station\, 100 Morris Street\, Morristown \n\n\n\n\nRegister Today!\n\n\n\n\n\n\n\n\nParticipants will have the opportunity to make a meaningful impact by assembling “Totes of Hope: Hospital Care Kits.” Volunteers will decorate a canvas tote bag with uplifting messages\, inspiring artwork or colorful designs\, then fill it with comforting essentials. Each tote becomes a heartfelt symbol of care and kindness\, offering encouragement to Patients of all ages and conditions. \n\n\n\nOur Totes of Hope will be distributed to Patients through RWJBarnabas Health/ Rutgers Cancer Institute and Inspira Health. \n\n\n\nWe hope you will join us! \n\n\n\nMember companies can send up to three participants at no charge!* It’s the perfect opportunity to network with fellow BioNJ Members while making a difference on behalf of pediatric Patients.  \n\n\n\nWe warmly invite your organization to consider sponsoring this meaningful community initiative in support of Patients across New Jersey. Please contact Randi Bromberg at RBromberg@BioNJ.org to learn more. \n\n\n\n*Registration is on a first-come\, first-served basis. Each location is limited to 150 volunteers. \n\n\n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2025-bionj-gives-back/ LOCATION:Bristol Myers Squibb\, 3401 Princeton Pike\, Lawrence Township\, NJ\, 08648\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/07/BioNJ-Gives-Back-Tote.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251204T083000 DTEND;TZID=America/New_York:20251204T150000 DTSTAMP:20260502T062927 CREATED:20251022T201516Z LAST-MODIFIED:20251202T193726Z UID:17014-1764837000-1764860400@bionj.org SUMMARY:2025 BioNJ Inspiring STEM Conference DESCRIPTION:INFORM\, INVOLVE\, INSPIREIgniting Ideas & Advancing Bold Futures\n\n\n\nThursday\, December 4\, 2025 | 8:30 a.m.-3:00 p.m. Genmab\, 777 Scudders Mill Road\, Bldg. 2\, 1st Floor\, Plainsboro 08536Registration for BioNJ Members is $330 and $430 for Future Members.\n\n\n\n\nRegister Today!\n\n\n\nBecome a Sponsor\n\n\n\n\nBioNJ is thrilled to unveil the agenda for our upcoming Inspiring STEM Conference\, taking place on Thursday\, December 4! \n\n\n\nEvolving from our highly regarded Inspiring Women in STEM Conference\, this year’s expanded program is designed to engage and empower all professionals across the STEM spectrum — from early-career talent to senior leadership. \n\n\n\nThe full-day event features a thoughtfully curated agenda addressing the most pressing and forward-looking topics shaping the future of science\, technology\, engineering and math. With a focus on actionable insights\, bold ideas and inclusive dialogue\, the conference promises to engage and energize everyone committed to advancing the future of STEM. \n\n\n\nFrom how AI is reshaping the STEM workforce to how the Gates Foundation is accelerating women’s health-focused R&D\, this forward-thinking program will leave you informed\, inspired and equipped to lead with impact in 2026 and beyond! \n\n\n\n \n \n \n \n \n \n\n TimeCheck Out the Agenda\n\n\n\n \n 8:30 a.m. – 9:00 a.m.\nRegistration & Networking Breakfast \n \n \n 9:00 a.m. – 9:15 a.m.\nWelcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nMarisol Mendez Peron\, Senior Vice President\, Communications & Corporate Affairs\, Genmab\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INFORMED: EDUCATIONAL TOPICS\n\n\n\n \n 9:15 a.m.– 10:15 a.m.\nLEAP Beyond AI: Reinventing Leadership & Human IntelligenceKeynote by Micheline Nader\, BSN\, MPH\, DESS\, Author\, Motivational Speaker & CEO\, Jesra Foundation \nIn this powerful session\, Ms. Nader will deliver a compelling blend of visionary insight and practical strategy\, offering a framework for thriving in a tech-driven world while staying grounded in purpose and well-being. Attendees will explore how to: \n\nLead with confidence in an AI-enabled world\nAchieve extraordinary\, sustainable results\nUnlock and elevate their inner genius\nPrevent burnout and prioritize personal health\nBuild a leadership legacy that lasts\n\nWalk away inspired\, equipped and ready to lead boldly — with clarity\, compassion and resilience. \n \n \n 10:15 a.m. – 10:45 a.m.\nNetworking Break & Exhibitor Showcase \n \n \n 10:45 a.m.– 11:45 a.m.\nPanel: How AI is Reshaping Workforce Identity\, Decision-Making and Leadership Priorities in STEM Fields \nAs AI rapidly transforms the STEM landscape\, leaders face a new frontier of challenges — and opportunities. This session explores how artificial intelligence is reshaping workforce identity\, decision-making processes\, and leadership priorities across scientific\, technical and clinical environments. Whether you're an executive\, team leader or emerging professional\, this session will offer practical insights on navigating change with confidence and clarity.Panelists: \n\nTahamtan Ahmadi\, M.D.\, Ph.D.\, Executive Vice President and Chief Medical Officer\, Head\, Experimental Medicines\, Genmab\nStephen K. Burley\, M.D.\, D.Phil\, Director\, Rutgers Artificial Intelligence and Data Science (RAD) Collaboratory\, Rutgers University\nRivers Cornelson\, Senior AI Consulting Lead\, Crowe\nTina Naser\, Partner\, Healthcare Life Sciences Industry\, IBM\nModerated by Meghan Condon\, Vice President\, Digital & AI\, Thermo Fisher Scientific\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INVOLVED: INTERACTIVE TOPICS TO PROMOTE ACTIONABLE TAKEAWAYS/STEPS FOR ALL\n\n\n\n \n 11:45 a.m. – 12:15 p.m.\nImagining and Defining Our Relationship with AITo foster networking\, collaboration\, and idea-sharing\, we’ll be facilitating fun table discussions over lunch. Topics will include: \n\nLeadership & Personal Influence\nCareer Growth & Skill Development\nWorkplace & Collaboration\nHealth\, Wellness & Personal Balance\nImagination & the Future of Work\nTrust\, Ethics & Responsibility\n\n \n \n 12:15 p.m. – 1:15 p.m.\nLunch\, Table Discussions & Exhibitor ShowcaseDiscussion led by Lynne Anderson\, Partner\, Faegre Drinker and Juliet Hart\, CEO & Founder\, Hart & Chin \n \n \n 1:15 p.m. – 1:45 p.m.\nDebrief on Table DiscussionsAfter lunch\, we’ll reconvene for table readouts to share insights and examples on how AI can support our leadership\, career growth\, work relationships — and even our well-being. \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeBE INSPIRED: INSIGHTS TO INSPIRE \n\n\n\n \n 1:45 p.m. – 2:45 p.m.\nSparking a New Era of Women-Centered Research and InnovationJoin us for a compelling conversation on the Gates Foundation’s landmark $2.5 billion commitment through 2030 to accelerate research and development focused exclusively on women’s health. This session will explore how the initiative aims to advance more than 40 innovations across five critical and historically underfunded areas — particularly those impacting women in low- and middle-income countries. Gain insight into the strategies\, priorities\, and transformative potential of this unprecedented investment in women’s health and well-being. \nPanelists:\n\nKatie Barletta M.D.\, Ph.D.\, FACOG\, Senior Global Medical Director\, Ferring Pharmaceutical\nRu Cheng\, M.D.\, FACOG\, Director\, Women's Health Innovations\, Gender Equality Division\, Gates Foundation\nVrunda Desai\, M.D.\, FACOG\, Vice President\, Medical Affairs & Clinical Surgery\, CooperSurgical\nModerated by Elizabeth Garner\, M.D.\, CEO\, Sena Therapeutics\n\n \n \n 2:45 p.m. – 3:00 p.m.\nClosing Remarks \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\nTahamtan Ahmadi\, M.D.\, Ph.D.Executive Vice President and Chief Medical OfficerHead\, Experimental MedicinesGenmab \n\n\n\n\n\n\n\n\n\nLynne AndersonPartnerFaegre Drinker \n\n\n\n\n\n\n\n\n\nKatie Barletta M.D.\, Ph.D.\, FACOGSenior GlobalMedical DirectorFerring Pharmaceuticals \n\n\n\n\n\n\n\n\n\nStephen K. Burley\, M.D.\, D.PhilDirector\, Rutgers Artificial Intelligence and Data Science(RAD) Collaboratory\, Rutgers University \n\n\n\n\n\n\n\n\n\nRu ChengM.D.\, FACOGDirectorWomen’s Health InnovationsGender Equality DivisionGates Foundation \n\n\n\n\n\n\n\n\n\n\n\nMeghan CondonVice PresidentDigital & AIThermo Fisher Scientific \n\n\n\n\n\n\n\n\n\nChristopher CozicExecutive Vice President & Chief People OfficerGenmab & BioNJ Board Member \n\n\n\n\n\n\n\n\n\nRivers CornelsonSenior AI Consulting LeadCrowe \n\n\n\n\n\n\n\n\n\nVrunda Desai\, M.D.\, FACOGVice PresidentMedical Affairs & Clinical SurgeryCooperSurgical \n\n\n\n\n\n\n\n\n\nElizabeth Garner\, MDCEOSena Therapeutics \n\n\n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nJuliet HartCEO & FounderHart & Chin \n\n\n\n\n\n\n\n\n\nMicheline Nader\, BSN\, MPH\, DESSAuthorMotivational Speaker & CEOJesra Foundation \n\n\n\n\n\n\n\n\n\nTina NaserPartner\, Healthcare Life Sciences IndustryIBM \n\n\n\n\n\n \n\n\n\n\n\nRegister today and plan to join us at BioNJ’s STEM Conference on December 4\, 2025. Registration for BioNJ Members is $330 and $430 for Future Members. \n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.   URL:https://bionj.org/event/2025-bionj-inspiring-stem-conference/ LOCATION:Genmab\, 777 Scudders Mill Road\, Bldg. 2\, 1st Floor\, Plainsboro\, New Jersey\, 08536\, United States ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/10/IWSTEM.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251117T083000 DTEND;TZID=America/New_York:20251117T144500 DTSTAMP:20260502T062927 CREATED:20250702T115254Z LAST-MODIFIED:20251114T210452Z UID:16066-1763368200-1763390700@bionj.org SUMMARY:2025 BioNJ Patient Advocacy Summit DESCRIPTION:Registration is now closed for this event. We look forward to seeing confirmed registrants on Monday at Bristol Myers Squibb. Please contact Randi Bromberg at RBromberg@BioNJ.org with questions or to be added to the wait list. \n\n\n\n\n\n\n\nThe Power of the Patient’s Voice\n\n\n\nMonday\, November 17\, 2025 • 8:30 a.m.-2:45 p.m. Bristol Myers Squibb\, 3401 Princeton Pike\, Lawrence Township\n\n\n\nAttendance is only open and free to ALL Patient Advocacy Organizations and R&D company Patient advocacy and government affairs professionals.  \n\n\n\n\nBecome a Sponsor\n\n\n\n\nJoin us for BioNJ’s 10th Annual Patient Advocacy Summit — a dynamic\, educational gathering designed to leave you with new tools to make a meaningful difference on behalf of Patients. This empowering day will bring together Patients\, Advocacy Groups\, Care Partners\, Clinicians\, Policymakers and R&D Professionals to connect\, share and collaborate around advancing Patient-centered care. \n\n\n\nWhy Attend?\n\n\n\n\nGain Tools You Can Use — whether you’re helping someone navigate coverage\, understand a diagnosis or access treatment.\n\n\n\nMake Your Voice Heard — join the conversation with healthcare leaders\, researchers and policymakers to help shape the future of care from a Patient-first perspective. \n\n\n\nBuild Your Network — find community among others who truly understand the challenges and rewards of this work. \n\n\n\nBe Inspired — through powerful stories of resilience\, innovation and progress you’ll leave empowered and ready to take action.\n\n\n\n\nFeaturing topics requested by the Patient advocacy community and a diverse roster of speakers\, we hope you join us for this important conversation! \n\n\n\nHot Topics on the Agenda:\n\n\n\n\nHealth Literacy― Helping Patients Understand and Engage in Their Care\n\n\n\nRegulatory Process ― What Does the FDA Look Like\n\n\n\nMedicaid in Motion ― Understanding & Managing Evolving Requirements\n\n\n\n340B at a Crossroad ― Reform\, Transparency & Accountability \n\n\n\nResilience\, Reinvention & Relentless Advocacy ― Keynote by Rob Long\, Executive Director of Uplifting Athletes\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nHear from Experts Driving These Conversations: \n\n\n\n\n\n\n\n\n\nCommissioner Sarah AdelmanNew Jersey Department of Human Services \n\n\n\n\n\n\n\n\n\nRuth P. Brogden\, MPHCare Partner & DirectorPublic Health Programs & Grants Center for Asian Health & Liver CenterCooperman Barnabas Medical Center \n\n\n\n\n\n\n\n\n\nMichael CalvoVice PresidentFederal Government AffairsBristol Myers Squibb \n\n\n\n\n\n\n\n\n\nKim Czubaruk\, JDVice President\, PolicyCancerCare \n\n\n\n\n\n\n\n\n\nJayne GershkowitzChief Patient Advocate EmeritaAmicus Therapeutics \n\n\n\n\n\n\n\n\n\n\n\nChristopher Gilligan\, M.D.Chief Medical & Quality OfficerRobert Wood Johnson University Hospital \n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nErika Kerber\, Esq.President & Executive DirectorCommunity Health Law Project \n\n\n\n\n\n\n\n\n\nRob LongExecutive DirectorUplifting Athletes \n\n\n\n\n\n\n\n\n\nIan McLaughlin\, Ph.D.Senior Vice PresidentGovernment Affairs & PolicyBioNJ \n\n\n\n\n\n\n\n\n\n\n\nCatina O’Leary\, Ph.D.President & CEOHealth Literacy Media \n\n\n\n\n\n\n\n\n\nJulie RaskinCo-founder & CEOCongenital Hyperinsulinism International (CHI) \n\n\n\n\n\n\n\n\n\nJudy SaydahCare Partner for a Child with Rett Syndrome \n\n\n\n\n\n\n\n\n\nWilliam S. Smith\, Ph.D.Senior Fellow & DirectorLife Sciences InitiativeThe Pioneer Institute \n\n\n\n\n\n\n\n\n\nJulie TierneyFormer\, Deputy Director\, FDACenter for Biologics Evaluation & Research PrincipalLeavitt Partners \n\n\n\n\n\n\n\n\n\n\n\nReverend Kimberly L. WilliamsPresident & CEOChoose Healthy Life \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\nAttendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2025-bionj-patient-advocacy-summit/ LOCATION:Bristol Myers Squibb\, 3401 Princeton Pike\, Lawrence Township\, NJ\, 08648\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251030T073000 DTEND;TZID=America/New_York:20251030T143000 DTSTAMP:20260502T062927 CREATED:20250616T154108Z LAST-MODIFIED:20251028T160707Z UID:15823-1761809400-1761834600@bionj.org SUMMARY:2025 BioNJ C-Suite Summit DESCRIPTION:Life Sciences Leadership Through Uncertainties\n\n\n\nThursday\, October 30\, 2025 | 7:30 a.m.-2:30 p.m.Bridgewater Marriott \, 700 Commons Way\, Bridgewater \n\n\n\nRegistration is $695 for BioNJ Members and $895 for Future Members \n\n\n\n\nRegister Today!\n\n\n\nBecome a Sponsor\n\n\n\n\nBiopharma leaders are navigating through a period of evolving dynamics marked by AI-driven acceleration in advancing breakthroughs in therapeutics and commercial capabilities against a backdrop of compressed product lifecycles\, mounting macroeconomic headwinds and disruptions in geopolitical order. \n\n\n\nJoin BioNJ and industry leaders on October 30 to explore these converging forces\, exchange proven resilience strategies and chart a course for sustaining innovation and growth in even the most unpredictable environments. With dedicated networking sessions built into the program — including opportunities to connect directly with speakers — this event is designed to foster meaningful dialogue and lasting connections among C-Suite leaders and industry innovators. \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\nLiz BarrettCEOUroGen Pharma \n\n\n\n\n\n\n\n\n\nMark CampbellCEOCivia Health \n\n\n\n\n\n\n\n\n\nMichael Cantor\, M.D. Vice PresidentData Technology & InnovationRegeneron \n\n\n\n\n\n\n\n\n\nBrian CurciAssociate PartnerData & Agentic AI Leader\, Life Sciences & HealthcareIBM \n\n\n\n\n\n\n\n\n\nNick Downing\, M.D.Managing DirectorBain Capital Life Sciences \n\n\n\n\n\n\n\n\n\n\n\nMarc FogartyPartnerEisnerAmper \n\n\n\n\n\n\n\n\n\nNick GarlowManaging DirectorRational 360 \n\n\n\n\n\n\n\n\n\nLaurie GeryHead\, Business Development& Licensing\, VaccinesSanofi \n\n\n\n\n\n\n\n\n\nHisham HamadehSenior Vice President Global Head of DataDigital & Artificial IntelligenceGenmab \n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\n\n\nAshutosh KatiyarExecutive DirectorCommercial Insights& AnalyticsOphthalmologyRegeneron \n\n\n\n\n\n\n\n\n\nMatthew B. Klein\, M.D.\, M.S.\, F.A.C.S.Chief Executive OfficerPTC Therapeutics \n\n\n\n\n\n\n\n\n\nJohn KoufosPresidentCottage Four Strategic Solutions \n\n\n\n\n\n\n\n\n\nDavid Kuninger\, Ph.D. Director\, R&DThermo Fisher Scientific \n\n\n\n\n\n\n\n\n\nEmer Leahy\, Ph.D.\, MBAPresident & CEOPsychoGenics & Chair\, BioNJ \n\n\n\n\n\n\n\n\n\n\n\nEvan LippmanExecutive Vice PresidentBusiness DevelopmentTeva Pharmaceuticals \n\n\n\n\n\n\n\n\n\nClive Meanwell\, M.D.\, Ph.D.ChairmanPopulation Health Partners \n\n\n\n\n\n\n\n\n\nChristine Ann Miller CEOMelinta Therapeutics  \n\n\n\n\n\n\n\n\n\nChris Mortko\, Ph.D.\, MBAVice President\, Head Search & Evaluation Business Development & LicensingMerck & Co. \n\n\n\n\n\n\n\n\n\nTim OplerManaging DirectorGlobal Healthcare GroupStifel \n\n\n\n\n\n\n\n\n\n\n\nEmilio RagosaPartner\, Managing Partner\, Short Hills\, Global Co-Chair\, Life Sciences and Healthcare SectorDLA Piper \n\n\n\n\n\n\n\n\n\nMaryAnne Rizk\, Ph.D.Head\, Healthcare & Life Sciences\, AIAmazon Web Services \n\n\n\n\n\n\n\n\n\nEduardo SchurUS Life SciencesCommercial Strategyand R&D LeadEY \n\n\n\n\n\n\n\n\n\nNauman ShahGlobal HeadInnovative MedicineBusiness DevelopmentJohnson & Johnson \n\n\n\n\n\n\n\n\n\nArda Ural\, Ph.D.Americas Life Sciences LeaderEY \n\n\n\n\n\nThank You To Our Sponsors URL:https://bionj.org/event/2025-bionj-c-suite-summit/ LOCATION:Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, New Jersey\, 08807\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/06/CSuite-Summit-2025.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251009T083000 DTEND;TZID=America/New_York:20251009T161500 DTSTAMP:20260502T062927 CREATED:20250701T191423Z LAST-MODIFIED:20251008T215043Z UID:16003-1759998600-1760026500@bionj.org SUMMARY:2025 AI & Digital Health Day DESCRIPTION:Catalyzing Responsible Al Adoption Across New Jersey’s Life Sciences Ecosystem!\n\n\n\nThursday\, October 9\, 2025 | 8:30 a.m. – 4:15 p.m.Princeton University\, Friend Center | 65 Olden St\, Princeton\, NJ 08540 \n\n\n\nRegistration is now closed for this event. We look forward to seeing confirmed registrants Thursday at the program. Please contact Danielle Campay at DCampay@BioNJ.org to be added to the wait list. Thank you.  \n\n\n\n\nBecome a Sponsor\n\n\n\n\nJoin BioNJ — alongside Morgan Stanley and DLA Piper\, and hosted by Princeton Precision Health at the Princeton University Friend Center — on October 9 for our Third Annual AI & Digital Health Day. This high-impact\, full-day event brings together industry leaders\, trailblazing startups\, regulatory voices and technology innovators to dive into real-world AI applications that are transforming biopharma today. \n\n\n\nWith New Jersey leading the charge in AI-driven life sciences innovation\, don’t miss your chance to gain practical insights\, build powerful connections and walk away with strategies you can apply immediately across your organization. \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nPlease note: While our speakers will be sharing valuable insights. Their remarks are intended for informational purposes only and should not be considered official advice\, guidance or endorsement. \n\n\n\nSpace is limited. So register today. Registration is $225 for BioNJ Members and $325 for Future Members. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Don’t miss this unique opportunity to gain critical insights\, build powerful connections\, and position yourself at the forefront of AI and digital health innovation. \n\n\n\n\n\n\n\n\n\nChris AbrahamAI LeadEmerging TechnologiesInsmed Incorporated \n\n\n\n\n\n\n\n\n\nMahiuddin Ahmed\, Ph.D.President & Chief Scientific OfficerVITRUVIAE  \n\n\n\n\n\n\n\n\n\nShervin AyatiBusiness Development ExecutiveIBM Research \n\n\n\n\n\n\n\n\n\nMcClain BrownAI GTM LeaderGoML \n\n\n\n\n\n\n\n\n\nMeng Cao\, Ph.D.Associate DirectorEngineering & Data SciencePsychoGenics \n\n\n\n\n\n\n\n\n\n\n\nDiego Chowell\, Ph.D. Assistant ProfessorIcahn School of Medicine at Mount Sinai \n\n\n\n\n\n\n\n\n\nChristopher ColucciVice President Information TechnologyInsmed \n\n\n\n\n\n\n\n\n\nAruna DontabhaktuniCo-Founder & CEORegKey \n\n\n\n\n\n\n\n\n\nMaureen EnnisCEOThrive Digital Era \n\n\n\n\n\n\n\n\n\nLauren GadsbyDirector of Global Digital HealthJohnson & Johnson \n\n\n\n\n\n\n\n\n\n\n\nHisham Hamadeh\, Ph.D.Senior Vice President & Global Head\, Data\, Digital & AIGenmab \n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nPaul Howard\, Ph.D.Executive DirectorPublic Policy &Corporate AffairsAmicus Therapeutics \n\n\n\n\n\n\n\n\n\nJae KimFDA PartnerDLA Piper \n\n\n\n\n\n\n\n\n\nJohn MakiCEOSerotonix \n\n\n\n\n\n\n\n\n\n\n\nMary Maples\, Esq.Deputy Chief Executive OfficerNew Jersey Economic Development Authority \n\n\n\n\n\n\n\n\n\nElizabeth McNeilly\, CFPExecutive DirectorPrivate Wealth AdvisorAlternative Investments DirectorPortfolio Management DirectorMorgan Stanley \n\n\n\n\n\n\n\n\n\nScott OgdenHead of AI LabsGenmab \n\n\n\n\n\n\n\n\n\nYuri Ostrovsky\, Ph.D.DirectorAI SolutionsOM1 \n\n\n\n\n\n\n\n\n\nRob OttTeam LeadAI/Digital Health & EntrepreneurshipBioNJ \n\n\n\n\n\n\n\n\n\n\n\nMark Parsonson\, CFAManaging DirectorHealthcare Investment BankingMorgan Stanley \n\n\n\n\n\n\n\n\n\nSarah PittmanExecutive Director Market ExecutiveMorgan Stanley \n\n\n\n\n\n\n\n\n\nEmilio RagosaPartner & Managing PartnerShort Hills OfficeDLA Piper \n\n\n\n\n\n\n\n\n\nDeiva Ramachandran Ph.D.Generative AI Practice LeaderIBM Consulting \n\n\n\n\n\n\n\n\n\nCorey SandersSenior Vice PresidentStrategyCoreWeave \n\n\n\n\n\n\n\n\n\n\n\nGuillermo Sapiro\, Ph.D.Augustine Family Professor\, Electrical & Computer EngineeringPrinceton Precision Health \n\n\n\n\n\n\n\n\n\nEllington WestCEO & Co-FounderSonavi Labs \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\nClick Here for Visitor Parking & Transportation \n\n\n\n\n\n\n\nThank You To Our Sponsors URL:https://bionj.org/event/2025-ai-digital-health-day/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/07/AI-Digital-Health-Color-No-Sponsors.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250917T120000 DTEND;TZID=America/New_York:20250917T133000 DTSTAMP:20260502T062927 CREATED:20250616T150404Z LAST-MODIFIED:20250908T175945Z UID:15813-1758110400-1758115800@bionj.org SUMMARY:2025 BioNJ IT/Cyber Briefing Webinar DESCRIPTION:Creating a Cybersecurity Culture in Life Sciences: Executives\, Employees & IT Team Up to Protect Innovation \n\n\n\nWednesday\, September 17\, 2025 • 12:00 p.m.-1:30 p.m. | Webinar \n\n\n\n\nRegister Now\n\n\n\n\nIn today’s rapidly evolving digital landscape\, cybersecurity is no longer just the responsibility of the IT department—especially for life sciences companies\, where sensitive patient data\, intellectual property (IP)\, and critical infrastructure are at stake. \n\n\n\nCreating a strong cybersecurity culture is a shared\, organization-wide responsibility. Executives must understand the risks and budget accordingly. Employees must embrace training and best practices. And IT must implement and uphold standards across the enterprise and with third-party vendors. \n\n\n\nThat’s why BioNJ’s IT/Cybersecurity Awareness Committee invites you to join us for an engaging and practical webinar\, “Creating a Cybersecurity Culture in Life Sciences: Executives\, Employees and IT Team Up to Protect Innovation.” \n\n\n\nDuring this session\, you’ll hear from a panel of industry experts who will explore: \n\n\n\n\nThe Executive’s Role: Why cybersecurity must be championed from the top\, how to align it with business objectives\, and how leadership can model secure behaviors that make security a core business value — not just a compliance checkbox.\n\n\n\nThe Employee’s Role: Why ongoing awareness and training are essential\, especially around phishing\, password hygiene\, data handling and incident reporting.\n\n\n\nThe IT Perspective: How IT can support organizational goals while implementing best practices\, managing vendor risk\, and scaling cybersecurity cost-effectively — even with limited resources.\n\n\n\n\nOur panel will share real-world success stories and practical\, scalable strategies —including how to leverage automation and existing tools to build a resilient security culture\, even in high-growth environments. \n\n\n\n\n\n\n\n\n\nJim AldridgeSenior Vice PresidentCybersecurity AdvisorMarshEmployee Perspective \n\n\n\n\n\n\n\n\n\nScott MegaffinPresident & CEOAdiso TherapeuticsExecutive Perspective \n\n\n\n\n\n\n\n\n\nSam Pierre-Louis\, Ph.D.Senior Vice President & Chief Information OfficerAmicus TherapeuticsIT Perspective \n\n\n\n\n\n\n\n\n\nLarry SamilowCo-Founder & Managing DirectorVerve Group ConsultingModerator \n\n\n\n\n\nDon’t miss this opportunity to gain practical knowledge and ask your pressing questions. Register today! Registration is FREE to BioNJ Members and $75 for Future BioNJ Members. \n\n\n\n\n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2025-bionj-it-cyber-briefing-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/05/IT-Cyber.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250912T090000 DTEND;TZID=America/New_York:20250912T103000 DTSTAMP:20260502T062927 CREATED:20250729T183942Z LAST-MODIFIED:20250813T164408Z UID:16223-1757667600-1757673000@bionj.org SUMMARY:2025 Life Sciences at a Turning Point: Surviving & Thriving Amid Tariffs\, Tax Policy & Capital Shifts DESCRIPTION:Life Sciences at a Turning Point: Surviving & Thriving Amid Tariffs\, Tax Policy & Capital Shifts\n\n\n\nFriday\, September 12\, 2025 | 9:00 a.m.-10:30 a.m. | Webinar\n\n\n\n\nRegister Today!\n\n\n\n\n\n\n\n\nGlobal policy shifts and market volatility are creating new challenges for biotech and pharma leaders. Get ahead of what’s coming with expert commentary on U.S. economic policy\, international trade dynamics and capital markets.  \n\n\n\nTopics include: \n\n\n\n\nAlso hear how industry finance leaders are responding to it all\n\n\n\nAn update on the latest status of the US macroeconomy\, including the strength of the labor market\n\n\n\nThe prospects for inflation returning to its 2% target level\n\n\n\nThe outlook for the Fed’s rate policy\n\n\n\n\nDon’t miss this opportunity to stay ahead in today’s dynamic environment. \n\n\n\nOur Experts Include: \n\n\n\n\n\n\n\n\n\nSara BonsteinChief Financial Officer Insmed \n\n\n\n\n\n\n\n\n\nNed HuxTax PartnerPwC \n\n\n\n\n\n\n\n\n\nNumi PrasadManager\, Health Industries Risk & Regulatory AdvisoryPwC \n\n\n\n\n\n\n\n\n\n\n\nPhilip SclafaniAdvisory Partner PwC \n\n\n\n\n\n\n\n\n\nDavid Wilcox\, Ph.D.Senior FellowPeterson Institute for International Economics \n\n\n\n\n\n\n\n\n\nMODERATORMichael LoschChief Financial Officer Signum Biosciences \n\n\n\n\n\nWho should attend this webinar: \n\n\n\nThis webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.  \n\n\n\nRegister today and join us for this must-attend webinar. Registration is FREE to BioNJ Members and $75 for Future BioNJ Members. Click here to register. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2025-life-sciences-at-a-turning-point-surviving-thriving-amid-tariffs-tax-policy-capital-shifts/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/02/BioNJ-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250910T090000 DTEND;TZID=America/New_York:20250910T154500 DTSTAMP:20260502T062927 CREATED:20250616T145028Z LAST-MODIFIED:20250909T185721Z UID:15802-1757494800-1757519100@bionj.org SUMMARY:2025 BioNJ Manufacturing Summit DESCRIPTION:Navigating the Evolving Biopharma Landscape\n\n\n\nWith Insights from McKinsey & Co.\n\n\n\nWednesday\, September 10\, 2025 | 9:00 a.m.-3:45 p.m.BeOne Medicines\, 311 Pennington Rocky Hill Rd\, Pennington \n\n\n\nRegistration is now closed for this event. We look forward to seeing confirmed registrants Wednesday at the program. Please contact Danielle Campay at DCampay@BioNJ.org with any questions. Thank you.  \n\n\n\n\nBecome a Sponsor\n\n\n\n\nBioNJ’s Manufacturing Summit offers valuable insights from thought leaders on timely and important topics affecting the industry\, such as microeconomic considerations for biopharma manufacturing\, supply chain: onshoring impacts\, workforce solutions and manufacturing innovation solutions.  \n\n\n\nAs a special highlight\, attendees will also enjoy a guided tour of BeOne’s state-of-the-art manufacturing facility — offering a firsthand look at innovation in action. \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nOur Speakers \n\n\n\n\n\n\n\n\n\nZainab Alali\, Ph.D.Director\, Biotechnology & Aseptic ManufacturingRaritan ValleyCommunity College \n\n\n\n\n\n\n\n\n\nRemy Brim\, Ph.D.Principal and Health & Life Sciences Practice LeadBGR Group \n\n\n\n\n\n\n\n\n\nJoananne CoffaroVice PresidentExternal Affairs\, Communication & AdvancementMiddlesex College \n\n\n\n\n\n\n\n\n\nCortney FarrellLaboratory Sales SpecialistDyna-Tech \n\n\n\n\n\n\n\n\n\nAaron R. Fichtner\, Ph.D. PresidentNew Jersey Council of County Colleges \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSean Goudy\, Ph.D.\, PE\,Vice PresidentSite Leader & General ManagerFerring Pharmaceuticals \n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nMatt HohorstVice PresidentARCO Design/Build \n\n\n\n\n\n\n\n\n\nRich LoughlinChief Commercial Office & Board MemberCMIC CMO USA \n\n\n\n\n\n\n\n\n\nMike MaurerVice President & General Manager of U.S. ManufacturingBeOne Medicines \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConrad MercuriusExecutive Director\, Workforce Development & Career EducationRaritan Valley Community College \n\n\n\n\n\n\n\n\n\nJeff MorellAssociate PartnerMcKinsey & Company \n\n\n\n\n\n\n\n\n\nFernando Muzzio Ph.D.Distinguished Professor of Chemical and Biochemical EngineeringRutgers University \n\n\n\n\n\n\n\n\n\nGonzalo Perez\, Ph.D.Assistant Vice President for Academic AffairsMercer County Community College \n\n\n\n\n\n\n\n\n\nJason RadfordSenior Vice PresidentStrategic PartnershipsBeOne Medicines \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCatherine Starghill\, Esq.Vice PresidentNew Jersey Council of County Colleges \n\n\n\n\n\n\n\n\n\nDerron StarkPartner\, Principal Strategy & TransactionsEY \n\n\n\n\n\n\n\n\n\nNorm StoffregenSenior Vice PresidentU.S. Site HeadEnzene \n\n\n\n\n\n\n\n\n\nTom SullivanExecutive Vice PresidentCBRE-Advisory & Transaction Services/Life Sciences Group \n\n\n\n\n\n\n\n\n\nJohn TomtishenManufacturing Committee Co-ChairBioNJ \n\n\n\n\n\n\n\n\n\n\n\nMichael Vreeland\, MSU.S. Site Head & Interim Head of U.S. Process DevelopmentProBio \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\nThank You to Our Sponsors \n\n\n\n\n\n\nJoin us on September 10 for this important conversation. Registration is $125 for BioNJ Members and $250 for Future Members. Click here to register. URL:https://bionj.org/event/2025-bionj-manufacturing-summit/ LOCATION:BeOne Medicines\, 311 Pennington Rocky Hill Rd\, Pennington\, New Jersey\, 08534 CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/06/Manufacturing-Summit-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250731T093000 DTEND;TZID=America/New_York:20250731T110000 DTSTAMP:20260502T062927 CREATED:20250701T153626Z LAST-MODIFIED:20250717T124138Z UID:15948-1753954200-1753959600@bionj.org SUMMARY:From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy DESCRIPTION:Webinar: From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy \n\n\n\nThursday\, July 31 | 9:30 a.m.-11:00 a.m. | Free to BioNJ Members \n\n\n\n\nREGISTER TODAY!\n\n\n\n\n\n\nBioNJ and Manatt Health invite you to a high-impact webinar exploring how today’s policy environment is transforming the economics\, strategy and logistics of bringing therapies to market. With federal action on drug pricing reform and pharmaceutical supply chain security accelerating\, life sciences leaders must adapt to a new set of constraints — and opportunities.  \n\n\n\nThis session will bring together legal\, policy and market experts to examine how the policies like the Inflation Reduction Act (IRA)\, the Most-Favored Nation Executive Order\, Budget Reconciliation and the BIOSECURE Act are reshaping drug development timelines\, manufacturing strategies and commercialization risk. From pricing pressures and exclusivity reform to reshoring incentives and funding models\, we’ll explore how business leaders can position their organizations for resilience and growth. \n\n\n\nKey Takeaways: Whether you’re charting policy risks\, optimizing your supply chain or planning for long-term growth\, this webinar will provide the strategic context and actionable guidance you need to stay ahead.  \n\n\n\n\n\nTopics \n\n\n\nDrug Pricing Reform \n\n\n\n\nHow IRA implementation\, MFN-style pricing and reconciliation policy are impacting pricing dynamics\n\n\n\nThe exclusivity debate and its implications for innovation\, especially in rare diseases\n\n\n\nThe evolving role of PBMs and pending legislative reforms aimed at transparency and cost control\n\n\n\n\nSupply Chain Resilience \n\n\n\n\nThe risks of global dependencies and policy moves to strengthen U.S.-aligned manufacturing\n\n\n\nOpportunities and challenges in reshoring and rebalancing biopharmaceutical production\n\n\n\nQuality\, cost and sourcing trade-offs in a geopolitically complex landscape\n\n\n\nNew federal funding pathways and financing models to support domestic production\n\n\n\nEmerging risks from proposals like “Pharma-Ron” and how to engage proactively\n\n\n\n\nIntegrated Business Strategy \n\n\n\n\nWhy commercialization\, sourcing\, manufacturing and logistics planning must be aligned with evolving policy\n\n\n\nHow to build resilience across the value chain — from pricing strategy to Patient delivery\n\n\n\n\nSpeakers \n\n\n\n\n\n\n\n\n\nNicholas W. Bath\, Jr.PartnerManatt Health \n\n\n\n\n\n\n\n\n\nMichael S. KolberPartnerManatt Health \n\n\n\n\n\n\n\n\n\nMelindah SharmaManaging DirectorManatt Health \n\n\n\n\n\n\n\n\n\nWhether you’re a CEO\, SVP\, Commercial Ops lead\, legal advisor or corporate affairs executive\, this session is designed to provide the strategic clarity you need to navigate today’s challenges — and tomorrow’s opportunities. \n\n\n\nRegister today and join us on July 31 for this must-attend webinar on biopharma policy shifts. Registration is FREE to BioNJ Members and $75 for Future BioNJ Members. URL:https://bionj.org/event/from-price-controls-to-production-lines-how-policy-is-reshaping-biopharma-strategy/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/06/Manatt-Header.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250626T120000 DTEND;TZID=America/New_York:20250626T133000 DTSTAMP:20260502T062927 CREATED:20250516T151725Z LAST-MODIFIED:20250612T175036Z UID:15566-1750939200-1750944600@bionj.org SUMMARY:Clinical Development Webinar DESCRIPTION:Master Protocols in Clinical Trials: Driving Innovation\, Efficiency & Patient-Centric Research \n\n\n\nThursday\, June 26 | 12:00 p.m.-1:30 p.m. | Webinar \n\n\n\n\nRegister Today for Free!\n\n\n\n\n\n\nMaster Protocols in Clinical Trials \n\n\n\n“Master protocols are innovative clinical trials designed with multiple sub-studies\, subgroup-populations\, and subprotocols. They aim to explore or evaluate multiple therapies or multiple subpopulations in parallel under a single overarching protocol\, with the characteristics of improving efficiency and establishing uniformity through standardization of procedures in clinical trials. Master protocols could help address scientific\, operational\, and competitive challenges in the existing drug development model.” ~AppliedClincialTrialsOnline.Com \n\n\n\n\n\nJoin us for an insightful FREE webinar exploring how Master Protocols are transforming the clinical trial landscape. Designed to increase efficiency and flexibility\, Master Protocols offer a unified approach to studying multiple therapies\, diseases or Patient subgroups under a single overarching framework. \n\n\n\nIn this session\, you’ll:  \n\n\n\n\nGain efficiency with Master Protocol\n\nOptimize resource allocation\n\n\n\nStreamline trial execution\n\n\n\n\n\nAccelerate drug development\n\nExpand quickly across indications\n\n\n\nSupport multiple launches \n\n\n\n\n\nEnhance Patient journey\n\nEncourage sub-studies within the same trial to assess variations of Patient treatment options\n\n\n\nBalancing innovation around validity and relevance with Patient-centered approaches\n\n\n\n\n\n\nLearning objectives include:  \n\n\n\n\nDefine the Master Protocol in drug development\n\n\n\nOutline key elements of a successful Master Protocol\n\n\n\nArticulate the regulatory considerations related to the FDA Guidance on Master Protocols\n\n\n\nAdapt the Master Protocol design for oncology to other therapeutic areas\n\n\n\n\nWhether you’re a clinical operations professional\, researcher or sponsor\, this webinar will equip you with strategic insights to drive innovation while keeping Patients at the center of trial design. \n\n\n\nSpeakers \n\n\n\n\nLincy George\, PharmD\, Vice President\, Global Regulatory Affairs\, Oncology\, Specialty Care Business Unit\, Sanofi  \n\n\n\nDr. George is a seasoned regulatory affairs professional with more than 20 years’ experience in large global pharmaceutical companies securing drug approvals for several high priority brands. She has broad cross functional experience with diverse teams in both development and commercial organizations\, working on launch brands as well as products in development. \n\n\n\n\n\n\n\n\n\nBradley Smith\, Ph.D.\, Vice President\, Translational Medicine\, IQVIA  \n\n\n\nDr. Smith is a recognized leader in biomarker and companion diagnostic development\, bringing deep experience across laboratory research\, clinical implementation and Patient care. He is a subject matter expert in drug and diagnostic strategy\, leading commercial planning and the integration of companion diagnostics in oncology and other therapeutic areas. His responsibilities include regulatory\, technical and scientific oversight ― including U.S. registration. \n\n\n\n\n\n\n\n\n\nKatherine Sugarman\, M.D.\, Senior Vice President\, Clinical Development Strategy\, Genmab \n\n\n\nDr. Sugarman possesses a wealth of experience and expertise in oncology clinical development\, both from academia and the pharmaceutical industry. As part of Genmab’s ongoing evolution in R&D\, Dr. Sugarman oversees the clinical development strategy of their pipeline\, ensuring strategic trial design\, and providing scientific\, medical and statistical analysis insights for the interpretation of clinical data to drive promising molecules forward to address high unmet medical needs for Patients.​  \n\n\n\n\n\n\n\n\n\nModerator: Prasad Subramaniam\, Ph.D\, PMP\, sMBA\, Associate Director\, Portfolio & Program Management\, Genmab \n\n\n\nDr. Subramaniam is currently Associate Director within the Development Program Management function at Genmab\, supporting late-stage oncology and hematology programs. He is an experienced drug development leader with over 12 years of combined academic and industry experience spanning program and stakeholder management\, product development and strategic insights and competitive intelligence across hematology\, immuno-oncology and solid tumors. \n\n\n\n\n\n\n\n\n\nChris Pullion\, DO\, Medical Director\, Soligenix \n\n\n\nDr. Pullion oversees Soligenix’s study protocol design and implementation\, safety and pharmacovigilance; assists with clinical operations and regulatory interactions; and reviews all study related reports\, assessments and data analysis. He has been the clinical lead on numerous research programs over the years\, including most recently Soligenix’ two Phase 3 studies where he oversaw everything from protocol design and conception through to drafting clinical study reports and preparation for new drug applications. \n\n\n\n\nDon’t miss this opportunity to advance your understanding of the future of clinical trials. Click here to register for free and join us on June 26! URL:https://bionj.org/event/clinical-development-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/05/Clinical-Development-Webinar.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250605T083000 DTEND;TZID=America/New_York:20250605T150000 DTSTAMP:20260502T062927 CREATED:20250408T161423Z LAST-MODIFIED:20250514T175355Z UID:15296-1749112200-1749135600@bionj.org SUMMARY:2025 BioNJ HR Conference DESCRIPTION:Adapt & Advance Amidst Ambiguity…Again \n\n\n\nThursday\, June 5\, 2025 | 8:30 a.m.-3:00 p.m. \n\n\n\nKean University | North Avenue Academic Building | 1000 Morris Ave.\, Union\, NJ \n\n\n\n\n\nBioNJ is recognized by SHRM to offer Professional Development Credits (PDCs) for SHRM-CP® or SHRM-SCP® recertification activities. This program is approved for 4 SHRM credits. \n\n\n\n\n\nRegistration is now open for BioNJ’s 12th Annual HR Conference taking place at Kean University on June 5. Come ready to connect with other life sciences HR professionals\, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.  \n\n\n\nJoin the BioNJ HR community for answers\, insights and a chance to contribute. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem. \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nCome ready to gather new and creative ideas\, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.  \n\n\n\nClick here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities\, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.  \n\n\n\n\n\n\n\n\n\n\nDownload Kean Campus Map URL:https://bionj.org/event/2025-bionj-hr-conference/ LOCATION:Kean University\, 1000 Morris Ave\, Union\, New Jersey\, 07083\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250520T120000 DTEND;TZID=America/New_York:20250520T133000 DTSTAMP:20260502T062927 CREATED:20250408T154916Z LAST-MODIFIED:20250515T170621Z UID:15276-1747742400-1747747800@bionj.org SUMMARY:2025 BioNJ Legal Compliance & Regulatory Forum Webinar DESCRIPTION:AI for Legal\, Regulatory & Compliance Professionals \n\n\n\nTuesday\, May 20 | 12:00 p.m.-1:30 p.m. | Webinar \n\n\n\n\nRegister Today for Free!\n\n\n\n\nPlease join us for a robust conversation focused on demystifying AI\, with insight from academia\, as well as legal and technology experts.  \n\n\n\nThe panel will: \n\n\n\n\nProvide a basic understanding for executives of ‘What is AI?’\n\n\n\nDistinguish AI from data analytics from an education and technology perspective\n\n\n\nDiscuss AI and data analytics expectations as included in the September 2024 U.S. DOJ Evaluation of Corporate Compliance Programs (ECCP) update and General Compliance Program Guidance (GCPG)\n\n\n\nProvide examples of ‘where to start’\, how biopharma companies have begun to utilize AI tools and what may be on the horizon\n\n\n\nDiscuss how agencies\, such as the Department of Justice\, FDA and Veterans Affairs have begun to deploy AI tools\n\n\n\nShare best practices for identifying and managing risks \n\n\n\nOutline anticipated changes to regulations and expectations with the Trump Administration\n\n\n\n\nPanelists: \n\n\n\n\n\n\n\n\n\nRachel BatykeferVice PresidentCIA & Compliance OperationsMallinckrodt Pharmaceuticals \n\n\n\n\n\n\n\n\n\nJacob Elberg\, J.D.Professor of LawFaculty Director\, Center for Health & Pharma LawSeton Hall University School of Law \n\n\n\n\n\n\n\n\n\nJeremy OsinskiPrincipalForensic & Integrity ServicesErnst & Young  \n\n\n\n\n\n\n\n\n\nAdam Solander\, J.D.PartnerKing & Spalding \n\n\n\n\n\n\n\n\n\nModeratorLisa Dwyer\, J.D.PartnerKing & Spalding \n\n\n\n\n\nJoin us virtually for this important conversation on May 20. Registration is open and free! \n\n\n\nBioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you may be prompted to reset your password. If you do not have an account\, you’ll need to create one. If you need assistance\, please call 609-890-3185. Thank you. URL:https://bionj.org/event/2025-bionj-legal-compliance-regulatory-forum-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/01/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250306T120000 DTEND;TZID=America/New_York:20250306T133000 DTSTAMP:20260502T062927 CREATED:20250131T142124Z LAST-MODIFIED:20250221T195549Z UID:13711-1741262400-1741267800@bionj.org SUMMARY:The New Trump Administration: Employment Law Update of What You Need to Know Now! DESCRIPTION:The New Trump Administration: Employment Law Update of What You Need to Know Now!\n\n\n\nThursday\, March 6\, 2025 | 12:00 p.m.-1:00 p.m. | Webinar\n\n\n\n\nRegister Today for FREE!\n\n\n\n\n\n\n\n\nMuch has happened in just the first few weeks of the Trump Administration. Many of the new directives directly impact the workforce and employee lifecycle. BioNJ is offering a FREE webinar to help our HR community understand the employment law aspects of these new developments. Join Lynne Anderson and her colleagues at Faegre Drinker for a discussion of how President Trump’s New Executive Orders impact HR.   \n\n\n\nTopics will include: \n\n\n\n\nThe immediate impact on DEI\, the OFCCP\, the EEOC\, AI and other workforce implications\n\n\n\nHow the recent changes to immigration policies impact the workplace.  \n\n\n\nWhat to expect regarding independent contractor classifications\, non-competes and what is happening with the NLRB\n\n\n\nHow New Jersey and other State laws need to be considered in tandem with the new Trump Executive Orders and policy developments \n\n\n\n\n*BioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you’ll be prompted to reset your password. If not\, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you. \n\n\n\nSpeakers: \n\n\n\n\nLynne Anne AndersonPartnerFaegre Drinker  \n\n\n\nMs. Anderson is an experienced trial lawyer and strategic counselor with a long history of working with life sciences clients on all aspects of the employment relationship. She leads the firm’s Pay Equity Team and co-leads its Affirmative Action Task Force. Ms. Anderson has received multiple recognitions including by Chambers USA as a “Leading Lawyer for Business”.  She Co-Chairs BioNJ’s HR and Inspiring Women of STEM Committees; is a member of Faegre Drinker’s Health & Life Sciences Industry Team and Co-Chaired the firm’s ERG\, Women Forward\, from 2011 to 2023. \n\n\n\n\n\n\n\n\n\nBeth CarlsonPartnerFaegre Drinker  \n\n\n\nMs. Carlson is an experienced business immigration lawyer with over 25 years of experience moving corporate talent across borders and counseling U.S. and international companies on complex immigration issues across all industries\, including life sciences. She manages all types of U.S. employment-based immigration matters and leads the firm’s immigration team. Ms. Carlson also advises clients on changes to government policy\, including continued heightened scrutiny from USCIS\, the Department of Labor and other government agencies. \n\n\n\n\n\n\n\n\n\nBrian HayesAssociateFaegre Drinker  \n\n\n\nMr. Hayes counsels clients on a variety of employment-related issues\, including discrimination\, harassment\, retaliation\, wage and hour claims\, employee mobility and trade secrets\, breach of contract and defamation. He has deep experience advising clients on severance and release agreements\, restrictive covenants and trade secrets\, worker classification\, creating employee handbooks and policies\, reductions in force\, leaves of absence\, wage and hour compliance and other employment law developments. \n\n\n\n\nDon’t miss this important discussion. We hope to see you on March 6\, for this FREE educational webinar! Click here to register. URL:https://bionj.org/event/the-new-trump-administration-employment-law-update-of-what-you-need-to-know-now/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/01/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250206T164500 DTEND;TZID=America/New_York:20250206T213000 DTSTAMP:20260502T062928 CREATED:20241204T142406Z LAST-MODIFIED:20250224T132049Z UID:13135-1738860300-1738877400@bionj.org SUMMARY:2025 BioNJ Annual Dinner Meeting & Innovation Celebration DESCRIPTION:Thursday\, February 6\, 2025 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick\n\n\n\n\nBecome a Sponsor\n\n\n\nPhoto Gallery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAward Presentation byDr. Sol J. BarerFormer ChairCelgene Corp.ChairTeva Pharmaceutical \n\n\n\n\n\n\n\n\n\nDr. Sol J. Barer HonoreeJayne GershkowitzChief Patient AdvocateAmicus Therapeutics \n\n\n\n\n\n\n\n\n\nJohn CrowleyPresident & CEOBiotechnology Innovation Organization \n\n\n\n\n\n\n\n\n\nHusseini Manji\, M.D.Professor\, Oxford University; Co-Chair\, UK Gov’t Mental Health Mission & Former Global Head\, NeuroscienceJohnson & Johnson \n\n\n\n\n\nASCII\n\n\n\nGrace ElineBrain Cancer Survivor& Founder\, With Grace \n\n\n\n\n\n\n\n\n\nRegister today and join us for BioNJ’s 32nd Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 6\, 2025\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nAs always\, many surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadershipby Dr. Barer himself to Chief Patient Advocate for Amicus Therapeutics Jayne Gershkowitz\n\n\n\nThe acclaimed Innovator Awards honoring 18 New Jersey companies that received a novel FDA drug approval in 2024\n\n\n\nThe presentation of the Heart of BioNJ Awards to Grace Eline\, Brain Cancer Survivor and Founder of With Grace\, and Dr. Husseini Manji\, Professor at Oxford Univ.\, Co-Chair of the UK Gov’t Mental Health Mission and Formal Neuroscience Global Head at Johnson & Johnson\n\n\n\nKeynote with President and CEO of the Biotechnology Innovation Organization John Crowley\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $540 and $625 for Future Members. Reserve a table for your Team today. Visit www.BioNJ.org for more information. \n\n\n\n*BioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you’ll be prompted to reset your password. If not\, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you. \n\n\n\n\n\n\n\n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities\, reserve a table and to place your organization in the spotlight.  URL:https://bionj.org/event/2025-bionj-annual-dinner-meeting-innovation-celebration/ LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/12/Annual-Dinner-Meeting-2025-Stacked.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250123T120000 DTEND;TZID=America/New_York:20250123T131500 DTSTAMP:20260502T062928 CREATED:20241211T224147Z LAST-MODIFIED:20250320T105240Z UID:13160-1737633600-1737638100@bionj.org SUMMARY:Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025 DESCRIPTION:Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025\n\n\n\nThursday\, January 23\, 2025 | 12:00 p.m.-1:15 p.m.\n\n\n\n\nRegister for FREE\n\n\n\n\nKick off 2025 with a comprehensive exploration of how cybersecurity risks are shaping the life sciences industry. As companies continue to innovate and bring groundbreaking therapies and products to market\, staying ahead of rapidly evolving cybersecurity regulations and threats is more important than ever. \n\n\n\nJoin BioNJ’s IT/Cybersecurity Awareness Committee on January 23 for an engaging virtual discussion\, “Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025.” \n\n\n\nOur panel of experts will share valuable insights on these timely and critical topics: \n\n\n\n\nFDA & Cybersecurity: Focus\, expectations and enforcement plansgement\, Finance and Procurement and Research & Development (R&D) Facilities Management\n\n\n\n2024 Year-In-Review: Key trends in cybersecurity risks\n\n\n\n2025’s New Law: Preparing for the New Jersey Data Privacy Act\n\n\n\n\nHear From These Thought Leaders: \n\n\n\n\n\n\n\n\n\nScott Christie\, J.D.PartnerMcCarter & English \n\n\n\n\n\n\n\n\n\nKatherine ClarkVice PresidentCyber Client AdvisorMarsh \n\n\n\n\n\n\n\n\n\nShane MoylanVice PresidentCyber InsuranceMarsh  \n\n\n\n\n\n\n\n\n\nModerator Larry SamilowCo-Founder\, Managing DirectorVerve Group Consulting \n https://fullertonradiology.org \n\n\n\n\n\nDon’t miss this opportunity to gain practical knowledge and ask your pressing questions. Register today! URL:https://bionj.org/event/securing-the-future-cyber-insurance-data-privacy-fda-perspectives-for-2025/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/12/IT-Cyber-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241210T000000 DTEND;TZID=America/New_York:20241210T235959 DTSTAMP:20260502T062928 CREATED:20240917T193337Z LAST-MODIFIED:20250320T105512Z UID:12670-1733788800-1733875199@bionj.org SUMMARY:BioNJ Gives Back: A Volunteer Opportunity to Help Patients DESCRIPTION:Tuesday\, December 10\, 2024 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAn Exclusive BioNJ Member Event \n\n\n\nDuring this year’s BioNJ Annual Dinner Meeting and Innovation Celebration\, Will Lewis\, the Chair and CEO of Insmed\, former BioNJ Chair and recipient of the 2024 Dr. Sol J. Barer Award\, delivered a heartfelt call to action. He urged our Members to consider actively engaging in community volunteering. \n\n\n\nIn response\, on December 10\, BioNJ will unite our Members for a collective giving initiative\, “BioNJ Gives Back.” During this volunteer program\, industry colleagues will have the opportunity to build a BioBear\, design a Superhero cape and write a heartfelt card for pediatric Patients throughout the State. \n\n\n\nBioNJ Member company representatives are invited to join us at either of our two volunteer locations to take part in this meaningful program. Member companies can send up to five participants at no charge*. Each participant will have the opportunity to build a BioBear\, design a Superhero cape and write a card which will be presented to a pediatric charity at the conclusion. \n\n\n\nTwo Locations/Times to Choose from on December 10: \n\n\n\n\n\n9:00 a.m.-11:00 a.m.Location: Insmed700 US 206Bridgewater Township\, NJ 08807  \n\n\n\n\nRegister for Insmed\n\n\n\n\n \n\n\n\n\n\n2:00 p.m.-4:00 p.m.Location: Genmab\, 777 Scudders Mill RoadPlainsboro\, NJ 08536 \n\n\n\n\nRegister for Genmab\n\n\n\n\n \n\n\n\n\n\nWe hope you will join us! Thank you for your consideration.If you’re having trouble registering\, please contact Randi Bromberg at RBromberg@bionj.org. \n\n\n\n*Registration is on a first-come\, first-served basis. Each location is limited to 150 volunteers. \n\n\n\n\n\n\n\nSuperhero Sponsor $10\,000 \n\n\n\n\n15 tickets (Each ticket is for one person to build a BioBear\, design a Superhero cape and write a card.)\n\n\n\nCompany logo on all promotions and the BioNJ website\n\n\n\nLogo on BioBear birth certificates\n\n\n\nPhoto opportunity with Patient organization leader as we present BioBears at the conclusion of the program at both sites\n\n\n\nAll participants will be invited to participate in a group photo\n\n\n\nExposure to media and legislators invited to the event (attendance not guaranteed)\n\n\n\n\nBioBear Sponsor $5\,000 \n\n\n\n\n10 tickets (Each ticket is for one person to build a BioBear\, design a Superhero cape and write a card.)\n\n\n\nCompany logo on all promotions and the BioNJ website\n\n\n\nLogo on BioBear birth certificates\n\n\n\nAll participants will be invited to participate in a group photo\n\n\n\nExposure to media and legislators invited to the event (attendance not guaranteed)\n\n\n\n\n\n\nHost Sponsors \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSuperhero Sponsor \n\n\n\n\n\nBioBear Sponsor \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nContact Randi Bromberg at RBromberg@BioNJ.org for more information or to become a sponsor! \n https://apothekebergheim.de URL:https://bionj.org/event/bionj-gives-back-a-volunteer-opportunity-to-help-patients/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/09/BioNJ-Gives-Back-2-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241206T083000 DTEND;TZID=America/New_York:20241206T143000 DTSTAMP:20260502T062928 CREATED:20240719T143909Z LAST-MODIFIED:20241024T122137Z UID:12386-1733473800-1733495400@bionj.org SUMMARY:2024 BioNJ Inspiring Women in STEM Conference DESCRIPTION:Friday\, December 6\, 2024 | 8:30 a.m.-2:30 p.m.Sanofi U.S.\, 55 Corporate Drive\, Bridgewater\, NJ 08807 \n\n\n\n\nRegister Today!\n\n\n\nBecome a Sponsor\n\n\n\n\nJoin us for BioNJ’s Tenth Annual Inspiring Women in STEM Conference on Friday\, December 6\, 2024. A thoughtfully curated agenda will allow participants to consider the most cutting-edge questions and essential and relevant topics of the day including Women’s Health Disparities\, AI-enabled Women’s Health\, and Powerful and Empowering Leadership\, wrapping up with a C-Suite leadership panel that is sure to inspire. Audience participation exercises and quality networking will make this a meaningful experience leaving attendees with actionable insights designed to inform\, involve and inspire. And this event promises to equip participants with the tools and ideas they need to impact their organizations. \n\n\n\n \n \n \n \n \n \n\n TimeCheck Out the Agenda\n\n\n\n \n 8:30 a.m. – 9:00 a.m.\nRegistration & Networking Breakfast \n \n \n 9:00 a.m. – 9:15 a.m.\nWelcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nRaquel Mura\, Head\, Global R&D Operations North America\, Sanofi\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INFORMED: EDUCATIONAL TOPICS\n\n\n\n \n 9:15 a.m.– 10:15 a.m.\nPanel: Addressing Women’s Health Disparities and AdvocacyThis session will explore women's health disparities and advocacy efforts\, offering an historical perspective to contextualize current challenges and advancements. Experts will discuss recent developments\, upcoming trends and key areas for intervention\, while collaborating on actionable steps to empower advocacy and drive meaningful change in women's health.Panelists: \n\nRachel Braun Scherl\, Managing Partner & Co-Founder\, SPARK Solutions for Growth\nElizabeth Garner\, M.D.\, Former Chief Scientific Officer\, Ferring Pharmaceuticals US\, Immediate Past President\, American Medical Women's Association\nDenise Rodgers\, M.D.\, Vice Chancellor\, Interprofessional Programs\, Rutgers University\n\nModerated by: Jen Radin\, US Healthcare Advisory Sector Leader & Founding Partner\, Deloitte Health Equity Institute\, Deloitte \n \n 10:15 a.m.– 11:00 a.m.\nPanel: AI & Advancing Women’s HealthOur experts will delve into how AI technologies are revolutionizing diagnostics\, treatment options and personalized care for women worldwide. From predictive analytics to precision medicine\, discover how AI is reshaping healthcare delivery\, improving outcomes and promoting equity in women’s health initiatives.Panelists: \n\nNidhal Bouaynaya\, Ph.D.\, Associate Dean\, Henry M. Rowan College of Engineering\, and Professor of Electrical and Computer Engineering\, Rowan University\nBrianna Brennan\, Chief Innovation Officer\, Ontrak Health\nKirthika Parmeswaran\, Chief Executive Officer\, Vital Start Health\n\nModerated by:  Maureen Cruz\, Ph.D\, MPH.\, Director\, Science\, Regulation & Policy\, Faegre Drinker Biddle & Reath LLP \n \n \n 11:00 a.m. – 11:15 a.m.\nNetworking Break & Exhibitor Showcase \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INVOLVED: INTERACTIVE TOPICS TO PROMOTE ACTIONABLE TAKEAWAYS/STEPS FOR ALL\n\n\n\n \n 11:15 a.m. – 11:45 a.m.\nLeading From Where You Are: Women’s Power Advocacy & InfluenceKeynote by: Alison Fragale\, Ph.D.\, Speaker\, Professor & Compulsive OrganizerHow can women confidently advocate for their careers and ideas? Dr. Fragale will answer with six key strategies that anyone\, regardless of title\, can use to speak up and influence effectively without being seen as "aggressive" or "self-promoting." She'll discuss the importance of setting long-term goals\, excelling in performance\, becoming an "other promoter\," while developing your own narrative cultivating status and power and strategically saying yes or no. \n \n \n 11:45 a.m. – 12:00 p.m.\nIntroduce Workshop / Table Discussion Topics \n \n \n 12:00 p.m. – 1:00 p.m.\nLunch & Table Discussions/Workshop & Exhibitor Showcase \n \n \n 1:00 p.m. – 1:30 p.m.\nDebrief on Table Discussions/Workshop \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeBE INSPIRED: INSIGHTS TO INSPIRE \n\n\n\n \n 1:30 p.m. – 2:30p.m.\nPanel: Women C-Suite Executive PanelJoin us for an inspiring panel where leaders will share their personal journeys and insights on navigating the C-Suite. You'll gain valuable perspectives on leadership\, innovation and overcoming challenges in both corporate and entrepreneurial settings. Whether you're aiming to advance your career\, reach the C-Suite or become an entrepreneur\, this session offers invaluable lessons and inspiration from accomplished women shaping today’s business world.Panelists: \n\nJennifer D'Angelo\, Chief Operating Officer & Executive Vice President\, Healthcare\, New Jersey Innovation Institute\nSandy Milligan\, M.D.\, J.D.\, President\, Research & Development\, Laboratory Operations\, IT & HR\, Aspira Women's Health \nEileen Morrissey\, Founder & CEO\, MedifVU\nKatie Sugarman\, M.D.\, Senior Vice President & Head\, Clinical Strategy\, Genmab\n\nModerated by: Cecilia Fong\, Director\, Business Insights & Analytics\, Genmab \n \n \n 2:30 p.m.\nClosing Remarks \n \n \n \n \n \n \n\n\n\n\n\nThank You to Our Sponsors\n\n\n\n\n\n\nRegister today and plan to join us at the Inspiring Women in STEM Conference on December 6\, 2024. Please share with colleagues and clients who can benefit from this informative program. Registration for BioNJ Members is $330 and $430 for Future Members. Bring your entire Team! \n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions. URL:https://bionj.org/event/2024-bionj-inspiring-women-in-stem-conference/ LOCATION:Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, New Jersey\, 07030\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/07/IWSTEM-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241121T120000 DTEND;TZID=America/New_York:20241121T131500 DTSTAMP:20260502T062928 CREATED:20241023T114719Z LAST-MODIFIED:20241104T185543Z UID:12952-1732190400-1732194900@bionj.org SUMMARY:BioNJ Finance Webinar DESCRIPTION:Post-Election Insights: Navigating Economic\, Tax & Policy Changes in Life Sciences\n\n\n\nThursday\, November 21\, 2024 | 12:00 p.m.-1:15 p.m.\n\n\n\n\nRegister for FREE\n\n\n\n\nJoin us for an engaging post-election webinar where industry experts will offer valuable insights into navigating the evolving landscape of economic\, tax and policy changes impacting the life sciences sector. This informative session promises to provide you with the strategies and knowledge needed to stay ahead in these rapidly changing times. \n\n\n\nTopics include: \n\n\n\n\nPost Election Discussion and the Impact on the Economy and the Industry\n\n\n\nMacro Environment & Trends\n\n\n\nTax & Policy Update\n\n\n\n\nDon’t miss this opportunity to stay ahead in today’s dynamic environment. \n\n\n\nOur Experts Include: \n\n\n\n\n\n\n\n\n\nTaylor HittleSenior ManagerWashington CouncilEY \n\n\n\n\n\n\n\n\n\nFred GordonSenior DirectorWashington NationalRSM \n\n\n\n\n\n\n\n\n\nMichael StrazzellaCo-ChairGovernment RelationsBuchanan Ingersoll& Rooney \n\n\n\n\n\n\n\n\n\nModerator:Sanjeev NarulaCFOIntra-Cellular Therapies \n\n\n\n\n\nWhether you’re involved in M&A\, technology\, finance or in the broader economic landscape\, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost. \n\n\n\nWho should attend this webinar: \n\n\n\nThis webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/bionj-finance-webinar/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/09/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241118T090000 DTEND;TZID=America/New_York:20241118T163000 DTSTAMP:20260502T062928 CREATED:20240318T181310Z LAST-MODIFIED:20241118T133412Z UID:11218-1731920400-1731947400@bionj.org SUMMARY:2024 BioNJ AI & Digital Health Day DESCRIPTION:Register Today\n\n\n\nBecome a Sponsor\n\n\n\n\nNovember 18\, 2024 | 9:00 A.M. – 4:30 P.M.Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, NJ\n\n\n\nThe event today is at the Tech Flex space in University Center Complex (UCC). You should have received an email from BioNJ which includes more details about the location and links to a campus map. The building is about halfway between the Howe Center and Babbio Center. Please plan to arrive early. Hoboken is congested in the morning\, and it can take time to get to campus. We look forward to seeing you there! \n\n\n\nJoin BioNJ\, in partnership with Morgan Stanley and DLA Piper and hosted by Stevens Institute of Technology\, on November 18 for our 2nd Annual AI & Digital Health Day.  \n\n\n\nFeaturing an exhilarating full-day program\, we’ll: \n\n\n\n\nExplore the latest trends in AI and digital health and how they are already impacting the life sciences industry\n\n\n\nDive into the challenges faced by entrepreneurs as they develop cutting-edge solutions to enhance Patient outcomes \n\n\n\nHear rapid-fire lightning pitches from entrepreneurial companies revolutionizing healthcare through AI-driven innovations (Interested in pitching? Click here to learn more and apply!)\n\n\n\n\nPlus\, entrepreneurs will have the opportunity to meet one-on-one to get advice from experts from financial\, legal\, investor and healthcare provider organizations at our Industry Help Desks.  \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nCampus Maphttps://assets.ctfassets.net/mviowpldu823/1RHE112FrlUHseuZoPDsRM/a6feb431cdb732d2a565191de33dd298/Stevens-Campus-map-2024-web.pdf \n\n\n\nDriving Directionshttps://www.stevens.edu/driving-directions-to-stevens \n\n\n\nVisit Websitehttps://www.stevens.edu/admission-aid/visit-stevens \n\n\n\nParking Resources \n\n\n\n*We recommend taking public transportation if you are able and leaving time to find parking* \n\n\n\nOff-Campus ParkingThere may be parking spaces available on nearby city streets\, but visitors should abide by the parking signs posted by the City of Hoboken. Parking in “Resident Only” spaces or on the side of a street scheduled for cleaning will result in a vehicle being ticketed\, booted\, or towed. \n\n\n\nHoboken Municipal Garages \n\n\n\n\nGarage D at 215 Hudson St.\n\n\n\nGarage D Parking | Find Parking | ParkMobile – this is the closest municipal parking lot to the University Center Complex at the Stevens Institute. Parking reservations can be made via this link.\n\n\n\nGarage G at 315 Hudson St.\n\n\n\n\nHoboken Private Garages \n\n\n\n\nRiver Street Garage at 333 River St.\n\n\n\nMaxwell Place Garage at 1025 Maxwell Ln.\n\n\n\nIndependence Garage at 2 12th St.\n\n\n\nLittle Man Parking Garage at 225 River St.\n\n\n\n\nThe following apps might be helpful in reserving spots in these private garages:Search | Propark MobilitySpotHeroParkChirp \n\n\n\nRegister today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $100 for BioNJ Members and $150 for Future Members. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2024-bionj-ai-digital-health-day/ LOCATION:Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, New Jersey\, 07030\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/03/AI-Digital-Health-Color-With-Sponsors.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241114T083000 DTEND;TZID=America/New_York:20241114T150000 DTSTAMP:20260502T062928 CREATED:20240613T123711Z LAST-MODIFIED:20241113T124114Z UID:12128-1731573000-1731596400@bionj.org SUMMARY:2024 BioNJ Patient Advocacy Summit DESCRIPTION:The Power of the Patient’s Voice\n\n\n\nThursday\, November 14 • 2024\, 8:30 a.m.-3:00 p.m.\n\n\n\nBristol Myers Squibb • 556 Morris Ave\, Summit\, NJ 07901 \n\n\n\nAttendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\n\nRegister Now\n\n\n\nBecome a Sponsor\n\n\n\n\n\n\n\n\nJoin us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients!  \n\n\n\nBioNJ’s Patient Advocacy Summit will bring together Patients\, Patient Advocacy Groups\, Caregivers\, Clinicians and R&D Professionals for a day of Education\, Engagement and Empowerment. Attendees will gain valuable tools and insights\, share best practices and meet key stakeholders within the health care ecosystem.  \n\n\n\nAttendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nThank You to Our Sponsor URL:https://bionj.org/event/2024-bionj-patient-advocacy-summit/ LOCATION:Bristol Myers Squibb\, 3401 Princeton Pike\, Lawrence Township\, NJ\, 08648\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241112T080000 DTEND;TZID=America/New_York:20241112T150000 DTSTAMP:20260502T062928 CREATED:20241015T150320Z LAST-MODIFIED:20241015T150640Z UID:12871-1731398400-1731423600@bionj.org SUMMARY:7th Annual Symposium for Life Science Innovation and Development DESCRIPTION:***Not a BioNJ Hosted Event*** \n\n\n\nA Special Full-Day Conference for Life Science\, Design and Real Estate Professionals \n\n\n\nBringing the life sciences innovation community together \n\n\n\nLaunched in 2018\, NY Metro Builds Bio+ focuses on the growth and development of the life science cluster in the Greater New York Metro area (which includes New York City and the surrounding counties of New York\, Connecticut\, New Jersey and Pennsylvania). NY Metro Builds Bio+ hosts a series of events and educational initiatives and generates research and reports. \n\n\n\nA 501(c)(3) nonprofit membership-driven organization\, NY Metro Builds Bio+ is dedicated to bringing the life sciences innovation community together\, serving as the go-to place to find information about and assistance with growing\, building and locating life science companies in the New York Metropolitan area.Join us at the Seventh Annual Symposium for Life Science Innovation and Development to hear how private and public investments are driving exponential growth for the life science industry\, what new initiatives are furthering innovation in the space and what this means for the Greater NY Metropolitan Area.The symposium will also highlight a new London/UK life sciences chapter and we’ll present the research report from the London life sciences study tour which took place in April 2024. \n\n\n\nClick here for more information. URL:https://bionj.org/event/7th-annual-symposium-for-life-science-innovation-and-development/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241107T120000 DTEND;TZID=America/New_York:20241107T130000 DTSTAMP:20260502T062928 CREATED:20241022T124806Z LAST-MODIFIED:20250320T105945Z UID:12921-1730980800-1730984400@bionj.org SUMMARY:Health Equity in Clinical Trials New Jersey Participant Demographics DESCRIPTION:Webinar: Health Equity in Clinical TrialsNew Hersey Participant Demographics \n\n\n\nThursday\, November 7\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister for FREE!\n\n\n\n\nBe among the first to hear the findings in BioNJ’s newly published whitepaper\, “Health Equity in Clinical Trials: New Jersey Participant Demographics\,” presented in partnership with Medidata\, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry. \n\n\n\nClinical trials represent a $15.2 billion industry in the U.S.\, with a continuing need for increased participation. \n\n\n\nTherefore\, this pioneering research tackles a critical goal: supporting the recruitment of underrepresented communities in clinical trials\, specifically in New Jersey\, while comparing New Jersey’s recruitment performance with similar states\, such as Connecticut\, Maryland\, Massachusetts and New York. \n\n\n\nJoin us on November 7 as our experts share key findings\, shed light on demographic recruitment variations across states and define crucial public policy opportunities to pursue more accurate demographic representation according to epidemiological data. \n\n\n\nBy attending\, you’ll gain insights to help ensure that clinical trials more accurately reflect and serve the diverse populations they aim to benefit. Click here to register for free. \n\n\n\nHear from: \n\n\n\n\n\n\n\n\n\nCaroline Der Nigoghossian\, PharmD\, MS\, BCCCPSenior Clinical Engagement Lead Medidata AI LabsMedidata Solutions \n\n\n\n\n\n\n\n\n\nIan McLaughlin\, Ph.D.Vice PresidentGovernment AffairsBioNJ \n\n\n\n\n\n\n\n\n\nEvon Okidi\, ScM\, MSSenior Data ScientistMedidata Solutions \n\n\n\n\n\nClick here to download a copy of “Health Equity in Clinical Trials: New Jersey Participant Demographics“. \n https://lancewallnau.com URL:https://bionj.org/event/health-equity-in-clinical-trials-new-jersey-participant-demographics/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/10/HECT-Outlines-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241024T170000 DTEND;TZID=America/New_York:20241024T190000 DTSTAMP:20260502T062928 CREATED:20241007T140338Z LAST-MODIFIED:20241023T114810Z UID:12860-1729789200-1729796400@bionj.org SUMMARY:Life Sciences Alternative Funding Panel DESCRIPTION:Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey. \n\n\n\nThis panel discussion will focus on securing funding from non-traditional sources\, and will address the following questions: \n\n\n\n\nHow will the next generation of drugs\, diagnostics\, and devices be funded?\n\n\n\nWhat new models are there that might change the paradigm?\n\n\n\nIs there a better way to fund early and emerging commercial biomedical research?\n\n\n\n\nPanelists Include: \n\n\n\n\nJosh Barer\, Managing Director at Hibiscus BioVentures\n\n\n\nJudith Sheft\, Executive Director\, NJ CSIT\n\n\n\nJorge Ramirez\, Vice President\, M&A and Business Development\, Quest Diagnostics\n\n\n\n\nModerated by John Pennett\, Partner\, Life Sciences and Technology Group\, Eisner Advisory Group LLC URL:https://bionj.org/event/life-sciences-alternative-funding-panel/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241022T120000 DTEND;TZID=America/New_York:20241022T130000 DTSTAMP:20260502T062928 CREATED:20240926T131152Z LAST-MODIFIED:20240926T131327Z UID:12772-1729598400-1729602000@bionj.org SUMMARY:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness DESCRIPTION:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness\n\n\n\nTuesday\, October 22\, 2024 | 12:00 p.m.-1:00 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nThe promise of cell therapies is often tempered by the many complexities of transitioning these innovations from R&D to the clinic. For early phase programs\, there are many aspects to consider\, from understanding evolving regulatory guidelines and reviewimg pathway options to addressing common manufacturing-related issues such as scalability\, high cost of goods\, and workforce retention. Additionally\, organizing and executing a successful cell therapy clinical trial can be challenged by a limited number of qualified clinical sites with experience in conducting advanced therapy studies\, access to desired Patient populations\, and managing the complex supply chain required to deliver therapies to Patients in a timely fashion. \n\n\n\nThrough a series of brief presentations on three key topic areas\, this webinar will help early phase cell therapy developers identify insights to mitigate risk and ensure clinical readiness to position their programs for success. \n\n\n\nSpecific topic areas of focus include: \n\n\n\n\nNavigating an evolving cell therapy regulatory landscape\n\n\n\nHow to assess GMP-readiness and prepare your cell therapy workflow for clinical and commercial manufacturing\n\n\n\nEnsuring patient-centricity in the complex cell therapy ecosystem and leveraging a unique\, comprehensive operating model for your product\n\n\n\n\nLearning objectives: \n\n\n\n\nStrategies to navigate regulatory hurdles and maximize impact of meetings with regulators\n\n\n\nBest practices to address common challenges in cell therapy process development and manufacturing\n\n\n\nOpportunities for a more streamlined\, Patient-centric approach to cell therapy clinical trials\n\n\n\nBenefits of working with an integrated CRO/CDMO partner to simplify the cell therapy value chain and improve Patient-centricity\n\n\n\n\nPresenters: \n\n\n\n\nMichele DugganSr. Manager\, Regulatory AffairsThermo Fisher Scientific  \n\n\n\nMs. Duggan joined Thermo Fisher Scientific in 2021 as Sr. Manager Regulatory Affairs supporting the development and delivery of regulatory solutions for customers within the biologics and advanced therapies pharma services manufacturing network. Prior to joining Thermo Fisher Scientific\, she spent over 17 years in CMC regulatory consulting\, providing regulatory strategy\, dossier authoring and review expertise for biologics and cell therapy products across all stages of the product life cycle. \n\n\n\n\n\n\n\n\n\nMindy Sadik\, Ph.D.Director\, Cell Therapy SciencesThermo Fisher Scientific  \n\n\n\nDr. Sadik oversees the Process Development and Analytical Development teams for the Cell Therapy Business unit for Advanced Therapies. Dr. Sadik’s teams work closely with partners to provide development and clinical scale services\, which include gene and non-gene modified cell processing for autologous and allogeneic cell therapies. This work includes technology transfer from the client to Thermo Fisher’s site\, process optimization and workflow readiness for transition into GMP manufacturing.  \n\n\n\n\n\n\n\n\n\nKim Watanabe\, Ph.D.Executive Director\, Cell and Gene Therapy Pillar HeadThermo Fisher Scientific  \n\n\n\nDr. Watanabe recently joined PPD\, part of Thermo Fisher Scientific\, where she leads business and operational strategy development and deployment in hematology and oncology clinical development services. She has 20 years of experience in R&D\, business and operations\, of which the last 14 years have been focused on cell and gene therapies. Prior to her current role\, Dr. Watanabe served as General Manager and Site Head for the Patheon Translational Services. Prior to her current role\, she served as GM/ Site Head for the Patheon Translational Services\, part of the contract development and manufacturing organization of Thermo Fisher Scientific. \n\n\n\n\n\n\n\n\nRegister today and join us on October 22 for this FREE educational webinar. Come ready to learn and ask questions! URL:https://bionj.org/event/positioning-early-cell-therapy-for-clinical-success-mitigating-risk-ensuring-gmp-readiness/ LOCATION:New Jersey END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241010T073000 DTEND;TZID=America/New_York:20241010T163000 DTSTAMP:20260502T062928 CREATED:20240318T181526Z LAST-MODIFIED:20241002T120610Z UID:11216-1728545400-1728577800@bionj.org SUMMARY:2024 BioNJ C-Suite Summit DESCRIPTION:THIS EVENT IS CLOSED TO THE MEDIA \n\n\n\nAn Inflection Point for Innovation in Life Sciences\n\n\n\nThursday\, October 10\, 2024 | 7:30 a.m.-4:30 p.m. Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, NJ \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAgainst a backdrop of change\, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change. \n\n\n\n \n \n \n \n \n \n\n TimeAGENDA\n\n\n\n \n 7:30 a.m. – 8:15 a.m.Registration & Networking Breakfast \n \n \n8:15 a.m. – 8:20 a.m.\n\n Welcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nEmer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeINNOVATION\n\n\n\n \n \n8:20 a.m. – 8:50 a.m.\n\nKeynote: The Next Wave of Innovation in Life Sciences \nLife sciences leaders are navigating a period of exciting innovation. Novel modalities and mechanisms of action have helped the industry address previously stubborn unmet needs. Over the past 10 years\, R&D spend has increased\, the pipeline has become more diverse and new asset approvals have accelerated. Looking ahead\, policy reforms (e.g.\, IRA)\, a rapid proliferation in technological resources (e.g.\, AI\, mRNA platforms) and a rise in cross-company collaborations suggest further change and opportunity. Join us in reflecting on what the future of life sciences innovation holds\, and implications for large cap pharma companies\, biotechs and life sciences investors.  \n\nBrandon Parry\, MBA\, Sr. Partner\, McKinsey & Company\n\n \n \n \n8:50 a.m. – 9:45 a.m.\n\nPanel: Harnessing Change to Deliver Impactful Innovation \nIndustry leaders will reflect on the state of innovation\, expected industry shifts\, latest thinking on development paradigms\, portfolio shifts\, the lasting implications of policy reforms\, the impact of technological evolutions\, talent priorities and more. \n\nGarrett Ingram\, President & CEO\, Cipla Therapeutics\nWill Lewis\, MBA\, J.D.\, Chair & CEO\, Insmed\nClive Meanwell\, M.D.\, Chair & Partner\, Population Health Partners\nTarek Rabah\, MBA\, President & CEO\, Otsuka Pharmaceuticals\nScott White\, MBA\, Chief Operations Officer\, NA Innovative Medicine\, Johnson & Johnson\nConversation Leader: Harriet Keane\, Ph.D.\, Partner\, McKinsey & Company\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimePOLICY\n\n\n\n \n \n9:45 a.m. – 10:15 a.m.\n\nFireside Chat: Policy Uncertainties in an Election Year \nThe past 18 months have borne witness to a rapidly evolving policy landscape (including but not limited to the IRA\, IP\, BIOSECURE) – with expected evolutions on the horizon compounded by a tumultuous election season. With the presidential election just a few weeks away\, this session will explore potential health policy changes and implications for industry leaders. \n\nHon. Jim Greenwood\, Former Congressman & Former President & CEO\, BIO \nHeather Meade\, Principal\, EY\nConversation Leader: Lisa LeCointe-Cephas\, J.D.\, Partner\, Compliance & Investigations & Global Chair\, Life Sciences Sector\, DLA Piper\n\n \n \n 10:15 a.m. – 10:30 a.m.\nNetworking Break \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeMARKET ACCESS\n\n\n\n \n 10:30 a.m. – 11:15 a.m.\nPanel: Market Access & ReimbursementThe market access landscape is intricate and constantly evolving\, with payers persistently refining their business models and strategies. This panel will explore the essential groundwork for securing optimal reimbursement and payer coverage\, which are crucial for ensuring Patient access to treatments and\, ultimately\, improving Patient care. The panel will also address key issues manufacturers face including changing legislation\, consolidation\, M&A\, gross to net and commercial launch planning. \n\nPaul Hunter\, Vice President\, Market Access and Commercial Operations\, Halozyme\nChristopher Jackson\, J.D.\, Managing Member\, The Law Office of Christopher S. Jackson\nJake McDowell\, Vice President\, Head\, Market Access\, Pricing and Value\, Partner Therapeutics\nConversation Leader: Tom Evegan\, Principal\, Strategy & Management Consulting; National Consulting Leader Life Sciences\, RSM\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeTALENT\n\n\n\n \n 11:15 a.m. – 12:00 p.m.\nPanel: Topics in Talent: Attraction\, Retention & DiversityIn the life sciences sector\, talent development is crucial for fostering innovation and addressing complex challenges. Companies are focused on developing the next generation of talent by providing opportunities for education\, training and mentorship. Additionally\, there is a growing emphasis on upskilling and reskilling talent to leverage AI and other advanced technologies for greater efficiency and effectiveness. This discussion will explore key learnings from workplace evolutions and strategies companies can and must adopt such as equity. \n\nBritt Byers\, Executive Vice President\, Human Resources NA\, Kyowa Kirin\nVikki Conway\, Sr. Vice President & Head\, Human Resources\, U.S.\, Teva Pharmaceuticals\nKiran Dattani\, MPH\, MBA\, Customer Success\, Transformation\, Strategy & Architecture\, Google Cloud Healthcare & Life Sciences\, Google\nConversation Leader: Jan Campbell\, Managing Partner Pharmaceuticals & Biotechnology\, Korn Ferry\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeRESEARCH & DEVELOPMENT\n\n\n\n \n 12:00 p.m. – 12:30 p.m.\nFireside Chat: Research & Development in Mental HealthWith Global Mental Health Day as the backdrop\, this discussion features two pioneers in mental health research and development and will explore the challenges in developing therapeutics in the mental health space and how they can provide learnings in other areas. \n\nHusseini Manji\, M.D.\, F.R.C.P.C.\, Professor\, Oxford University; Co-Chair\, UK Govt MH Mission; Former Global Head\, Neuroscience\, Janssen/Johnson & Johnson\nConversation Leader: Emer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n \n \n 12:30 p.m. – 1:30 p.m.\nNetworking Lunch \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCOMMERCIALIZATION & PATIENT SERVICES\n\n\n\n \n 1:30 p.m. – 2:15 p.m.\nPanel: Continued Evolutions in Go-to-Market Models Including Patient ServicesThe continued evolution of the go-to-market (GTM) commercial model in life sciences has been characterized by a shift from push to pull strategies\, the development of novel roles that rethink traditional functional boundaries in a compliant manner\, and a simplification of the customer interface. This talk will explore how these approaches can enhance and improve Patient access to treatments given the complex journey that is the Patient experience. Getting it right can have a major impact on Patient outcomes\, as Patient experience in healthcare continues to lag. personalized journeys. \n\nJohn Harlow\, Chief Commercial Officer\, Melinta Therapeutics\nRohan Jain\, General Manager\, Commercial\, Nusano\nGina Murdoch\, MBA\, President & CEO\, Multiple Sclerosis Association of America\nConversation Leader: Haripriya Jain\, MS\, MBA\, Executive Director\, Global Value & Access Consulting\,  Evidera\, part of Thermo Fisher Scientific \n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCAPITAL MARKETS\n\n\n\n \n 2:15 p.m. – 3:00 p.m.\nPanel: Evolving Capital Markets & Implications for InnovationThe life sciences industry market cap has more than tripled in a decade despite more recent challenges. This discussion will explore the latest funding environment (e.g.\, IPOs) and implications for industry. \n\nAamir Mecklai\, Managing Director\, Healthcare Investment Banking\, Bank of America\nChristopher Mortko\,MBA\, Ph.D.\, Vice President\, Business Development & Licensing\, Merck & Co.\nMonika Vnuk\, M.D.\, Sr. Vice President\, Global Partnering & Business Development\, Sanofi\nConversation Leader: Arda Ural\, MBA\, Ph.D.\, Americas Life Sciences Sector Leader\, EY\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeAI & TECHNOLOGY\n\n\n\n \n 3:00 p.m. – 3:45 p.m.\nPanel: The Digital & AI Era in the Biopharma Industry: How Can Companies Across Functions Transition from Hype Into Reality?In the current environment\, the biopharmaceutical industry is experiencing a transformative shift towards digitalization and AI adoption\, promising improved efficiency\, innovation and Patient outcomes. However\, for companies to transition successfully from the hype surrounding these technologies into tangible benefits\, they must integrate digital and AI solutions across functions\, prioritize data-driven decision-making and foster a culture of innovation and adaptability. \n\nSydney Klein\, Chief Information Security Officer & Head of IT Core Services\, Bristol Myers Squibb\nHisham Hamadeh\, Ph.D.\, Sr. Vice President & Global Head\, Data Science & AI\, Genmab\nKeith Koharski\, MBA\, Executive Director\, Global Development IT\, Regeneron\nDeiva Ramachandran\, Ph.D.\, Partner\, Generative AI-Automation Practice Leader\, Healthcare\, Life Sciences\, State & Local Government\, IBM\nConversation Leader: Donna Conroy\, Founder\, CEO\, SciMar ONE\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nJoin us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to have maintained our pricing unchanged for the past three years.) Click here to register. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2024-bionj-c-suite-summit/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/03/CSuite-Summit-2024.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240926T120000 DTEND;TZID=America/New_York:20240926T133000 DTSTAMP:20260502T062928 CREATED:20240719T135506Z LAST-MODIFIED:20240829T163911Z UID:12354-1727352000-1727357400@bionj.org SUMMARY:AI & Digital Health Webinar DESCRIPTION:The Path to Real Impact of AI on Healthcare and Life Sciences\n\n\n\nThursday\, September 26\, 2024 | 12:00 p.m.-1:30 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nJoin us on September 26 for a complimentary webinar\, where leading industry experts will share insights into how they are leveraging AI and cutting-edge technology to drive innovation\, expand access and enhance Patient outcomes. Don’t miss this opportunity to gain valuable knowledge from those at the forefront of transformative advancements. \n\n\n\nSpeakers Include: \n\n\n\n\nKiran DattaniCustomer SuccessTransformation\, Strategy & Architecture Google Cloud \n\n\n\nMr. Dattani is a seasoned AI Specialist & Technologist with over 20 years of experience in the life sciences and pharmaceutical industries. He has a proven track record of driving AI & digital transformation\, automation and data science initiatives for leading organizations like Pfizer and Google. Mr. Dattani’s expertise spans AI healthcare practice\, enterprise architecture\, cloud enablement\, AI and data solution delivery. He has a passion for leveraging technology to improve Patient outcomes. \n\n\n\n\n\n\n\n\n\nSeemi KazmiExecutive DirectorProduct Management\, Digital HealthBristol Myers Squibb \n\n\n\nMs. Kazmi is Executive Director and Digital Health TA Lead for Cardiovascular and Neuroscience. She is responsible for defining digital health strategy and implementing innovative solutions across the pharma value chain\, both in commercial and clinical development. Ms. Kazmi is responsible for the global roadmap of a portfolio of solutions that includes first-in-class AI-based algorithms for Patient identification and clinical decision support\, biometric sensors/wearables for remote Patient monitoring\, tools integrated into EMRs and novel digital biomarkers of disease. \n\n\n\n\n\n\n\n\n\nScott OgdenHead\, AI LabsGenmab \n\n\n\nMr. Ogden heads up the AI Innovation Lab at Genmab\, where he’s focused on bringing leading\, novel solutions to the forefront of biotech. With a background in computation\, Mr. Ogden has spent his working years building healthcare innovation teams across the different sectors\, including payors and providers. He’s currently juggling his role at Genmab with working on his EMBA at Wharton\, studying entrepreneurship. During the program\, he will share some down-to-earth insights on how Genmab is using AI to push the envelope on the end-to-end drug development lifecycle. \n\n\n\n\n\n\n\n\n\nTroy Sarich\, Ph.D.Chief Commercial Data Science OfficerJohnson & Johnson Innovative Medicine \n\n\n\nDr. Sarich leads teams that leverage the power of artificial intelligence and machine learning\, real-world evidence (RWE)\, digital health and precision medicine across J&J’s global regions and multiple therapeutic areas. During his nearly 20-year tenure at J&J\, Dr. Sarich has delivered business transformation and Patient impact across the Innovative Medicine sector’s R&D and Commercial teams\, including as Vice President\, RWE\, Global Head of R&D Strategy\, founding co-chair and member of the J&J AI Council and in pivotal roles in the clinical development of INVOKANA® and XARELTO®. \n\n\n\n\n\n\n\n\nBioNJ is building a Directory of AI Service Providers. If you are a BioNJ Member and fit into this category\, send your company information to RBromberg@BioNJ.org! URL:https://bionj.org/event/ai-digital-health-webinar/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/07/Digital-Health-Webinar.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240913T083000 DTEND;TZID=America/New_York:20240913T154500 DTSTAMP:20260502T062928 CREATED:20240501T201159Z LAST-MODIFIED:20240912T152127Z UID:11637-1726216200-1726242300@bionj.org SUMMARY:2024 BioNJ Manufacturing Briefing DESCRIPTION:Building the Future: Advancing Capabilities\, Technology and Talent for the Next Era of Biomanufacturing\n\n\n\nFriday\, September 13\, 2024 | 8:30 a.m.-3:45 p.m. Sanofi\, 55 Corporate Dr\, Bridgewater\, NJ \n\n\n\nRegistration is now closed for this event. We look forward to seeing everyone tomorrow at the program. Please contact Maria Carapucci at MCarapucci@BioNJ.org with any questions. Thank you.  \n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry. URL:https://bionj.org/event/2024-bionj-manufacturing-briefing/ LOCATION:Sanofi\, 55 Corporate Dr\, Bridgewater\, New Jersey\, 08807\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240627T120000 DTEND;TZID=America/New_York:20240627T131500 DTSTAMP:20260502T062928 CREATED:20240523T201528Z LAST-MODIFIED:20240711T141128Z UID:11913-1719489600-1719494100@bionj.org SUMMARY:2024 BioNJ IT/Cyber Briefing Webinar DESCRIPTION:FREE Webinar: De-Risking Cybersecurity forEmerging Life Sciences Companies \n\n\n\nThursday\, June 27\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ’s IT/Cybersecurity Awareness Committee on June 27 for a virtual discussion on “De-risking Cybersecurity for Emerging Life Sciences Companies.” Few industries are as heavily targeted by cybercriminals as life sciences. It’s easy to see why…given the immense value of Patient data\, research\, market insights and product information. And emerging life sciences companies face even greater risks\, as they often have limited operational budgets for cybersecurity personnel and infrastructure. \n\n\n\nDuring this content-dense webinar\, we’ll hear from current life sciences CEOs\, CFOs and CIOs about the real-world cybersecurity challenges facing emerging companies. Additionally\, cybersecurity industry experts — including the FDA — will share some of the practical ways to address those challenges.  \n\n\n\nRegister today and come ready to ask our experts questions. \n\n\n\nHear from These Thought Leaders\n\n\n\n\n\n\n\n\n\nJim AmbrosiniChief InformationSecurity OfficerCompassMSP \n\n\n\n\n\n\n\n\n\nSusan BlumChief Financial OfficerMelinta Therapeutics \n\n\n\n\n\n\n\n\n\nDaniel BurkeDivision Chief\, Cyber OperationsOffice of Criminal InvestigationsU.S. Food and DrugAdministration \n\n\n\n\n\n\n\n\n\nPaul FangSr. Director\, InformationSecurity & ComplianceBeiGene \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRandy MilbyCEO & ChairTharimmune \n\n\n\n\n\n\n\n\n\nMark PelligrinoSr. Vice PresidentChief Information OfficerInsmed \n\n\n\n\n\n\n\n\n\nChris RiosSr. Vice PresidentMarsh \n\n\n\n\n\n\n\n\n\nModeratorLarry SamilowCo-Founder & Managing DirectorVerve Group Consulting \n\n\n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/bionj-it-cyber-briefing-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/05/IT-Cyber.png END:VEVENT END:VCALENDAR